Evidence map›Paper›PMID 31486227›Full record

ReviewEMBO molecular medicine2019

Dyslipidemia in retinal metabolic disorders.

Zhongjie Fu, Chuck T Chen, Gael Cagnone, Emilie Heckel, Ye Sun, Bertan Cakir, Yohei Tomita, Shuo Huang, Qian Li, William Britton and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in EMBO molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The roles of glycerophospholipids in the aging retina and age-related macular degeneration.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Targeted lipidomics uncovers oxylipin perturbations and potential circulation biomarkers in Bietti's crystalline dystrophy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Zhongjie FuDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-8182-2983
Chuck T ChenNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Gael CagnoneDepartment of Pediatrics, Pharmacology and Ophthalmology, CHU Sainte-Justine Research Center, Université de Montréal, Montreal, QC, Canada.
Emilie HeckelDepartment of Pediatrics, Pharmacology and Ophthalmology, CHU Sainte-Justine Research Center, Université de Montréal, Montreal, QC, Canada.
Ye SunDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Bertan CakirDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Yohei TomitaDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Shuo HuangDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Qian LiBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
William BrittonDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Steve S ChoDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Timothy S KernCenter for Translational Vision Research, Gavin Herbert Eye Institute, Irvine, CA, USA.
Ann HellströmSection for Ophthalmology, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Jean-Sébastien JoyalDepartment of Pediatrics, Pharmacology and Ophthalmology, CHU Sainte-Justine Research Center, Université de Montréal, Montreal, QC, Canada.
Lois Eh SmithDepartment of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0001-7644-6410
Boston Children's Hospital · USCentre Hospitalier Universitaire Sainte-Justine · CABeijing Tongren Hospital · CNNational Institutes of Health · USUniversity of Gothenburg · SE

Funding

Dietary control of angiogenesis in retinopathy modelsR01EY017017 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Zhongjie Fu, Lois Smith · 2006 to 2026
$11.8M
Novel therapies to inhibit Diabetic RetinopathyR24EY024864 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KERN, TIMOTHY S · 2015 to 2019
$8.1M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI CHEN, CHINFEI · 2016 to 2020
$5.2M
Role of Photoreceptors in the Pathogenesis of Diabetic RetinopathyR01EY022938 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KERN, TIMOTHY S · 2013 to 2021
$3.7M
Photoreceptor Determination of Retinal Blood Vessel Growth in RetinopathyR01EY029238 · NEI · BOSTON CHILDREN'S HOSPITAL · PI YE SUN · 2019 to 2026
$2.6M
The Mechanism of Immune-Vascular Crosstalk in RetinopathyR01EY030140 · NEI · BOSTON CHILDREN'S HOSPITAL · PI SUN, YE · 2019 to 2023
$2.0M
BCH | Manton Center for Orphan Disease Research, Boston Children's Hospital (Manton Center) 96307Beijing Municipal Natural Science Foundation #7192039Blind Children's Center 89282BLRD VA IK6 BX003604Boston Children's Hospital (BCH) 1U54HD090255De Blindas Vanner and Kronprinsessan Margaretas Arbetsnamnd for synskadade ALFGBG-717971Deutsche Forschungsgemeinschaft (DFG) CA 1940/1-1European Commission (EC) 305485HHS | NIH | National Eye Institute (NEI) 1R24EY024868HHS | NIH | National Eye Institute (NEI) EY017017Manpei Suzuki Diabetes FoundationNEI NIH HHS R01 EY017017NEI NIH HHS R01 EY022938NEI NIH HHS R01 EY029238NEI NIH HHS R01 EY030140NEI NIH HHS R24 EY024864NICHD NIH HHS U54 HD090255NIH HHS R01EY030140The Swedish Research Council DNR# #2016-01131
6 · The paper itself

Abstract

The light-sensitive photoreceptors in the retina are extremely metabolically demanding and have the highest density of mitochondria of any cell in the body. Both physiological and pathological retinal vascular growth and regression are controlled by photoreceptor energy demands. It is critical to understand the energy demands of photoreceptors and fuel sources supplying them to understand neurovascular diseases. Retinas are very rich in lipids, which are continuously recycled as lipid-rich photoreceptor outer segments are shed and reformed and dietary intake of lipids modulates retinal lipid composition. Lipids (as well as glucose) are fuel substrates for photoreceptor mitochondria. Dyslipidemia contributes to the development and progression of retinal dysfunction in many eye diseases. Here, we review photoreceptor energy demands with a focus on lipid metabolism in retinal neurovascular disorders.

Indexed as

AnimalsDyslipidemiasEnergy MetabolismHumansLipid MetabolismMetabolic DiseasesPhotoreceptor CellsRetinal DiseasesdyslipidemiaFGF21photoreceptorretinal metabolismβ-oxidation

Identifiers

PMID31486227
PMCPMC6783651
OpenAlexW2972191834

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.